Expansion of human γδ T cells for adoptive immunotherapy using a bisphosphonate prodrug

Cancer immunotherapy with human γδ T cells expressing Vγ2Vδ2 T cell receptor (also termed Vγ9Vδ2) has shown promise because of their ability to recognize and kill most types of tumors in a major histocombatibility complex (MHC) ‐unrestricted fashion that is independent of the number of tumor mutatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Tanaka, Yoshimasa, Murata‐Hirai, Kaoru, Iwasaki, Masashi, Matsumoto, Kenji, Hayashi, Kosuke, Kumagai, Asuka, Nada, Mohanad H., Wang, Hong, Kobayashi, Hirohito, Kamitakahara, Hiroshi, Okamura, Haruki, Sugie, Tomoharu, Minato, Nagahiro, Toi, Masakazu, Morita, Craig T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834800/
https://www.ncbi.nlm.nih.gov/pubmed/29288540
http://dx.doi.org/10.1111/cas.13491

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5834800/
https://www.ncbi.nlm.nih.gov/pubmed/29288540
http://dx.doi.org/10.1111/cas.13491

Ejemplares similares